Inhibrx, Inc. Quarterly Return On Equity in % from Q4 2019 to Q3 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Inhibrx, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2019 to Q3 2022.
  • Inhibrx, Inc. Return On Equity for the quarter ending September 30, 2022 was -1.26K %, a 742% decline year-over-year.
  • Inhibrx, Inc. annual Return On Equity for 2021 was -176 %, a 142% decline from 2020.
  • Inhibrx, Inc. annual Return On Equity for 2020 was 423 %, a 501% increase from 2019.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2022 -1.26K -1.11K -742% Jul 1, 2022 Sep 30, 2022
Q2 2022 -430 -315 -274% Apr 1, 2022 Jun 30, 2022
Q1 2022 -246 +51.3 +17.2% Jan 1, 2022 Mar 31, 2022
Q4 2021 -176 -600 -142% Oct 1, 2021 Dec 31, 2021
Q3 2021 -150 -274 -221% Jul 1, 2021 Sep 30, 2021
Q2 2021 -115 -187 -259% Apr 1, 2021 Jun 30, 2021
Q1 2021 -298 -376 -478% Jan 1, 2021 Mar 31, 2021
Q4 2020 423 +353 +501% Oct 1, 2020 Dec 31, 2020
Q3 2020 124 Jul 1, 2020 Sep 30, 2020
Q2 2020 72.4 Apr 1, 2020 Jun 30, 2020
Q1 2020 78.7 Jan 1, 2020 Mar 31, 2020
Q4 2019 70.5 Oct 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.